Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
14
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Burleighs Gin is a company that aims to establish itself as the leader in the gin market. It is the official gin partner for entities such as Leicester City Football Club, Leicester Tigers RFC, and the King Richard III foundation. Burleighs plans to introduce a 'non-alcoholic gin' apart from its gin products. The company feels that this will allow Burleighs to enter into the rapidly rising 'low & no' growth sector, now valued at £60 million a year in the UK. It also intends to commission the production of a 'Ready to Drink Gin & Tonic' in a can, another growth market driven by the popularity of gin that is now worth £472 million a year. Burleighs has on-trade listings secured with Cosy Club, Loungers, All Bar One, and Miller & Carter. It has hosted consumer events during 2019 including; Picnic in the Gardens, World Gin Day festival and The Great Burleighs Express. Burleighs Gin has been featured in BBC Good Food Guide's 'Best Gins to try in 2019'. They will use 50% of the investment for new product development, 15% for distillery expansion, 15% for recruitment drives, 10% for export growth, and 10% as marketing expenses.
days to go:
Expired
investment:
£130,490
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
Better Universal Grub (BUG) aspires to make edible insects mainstream and asserts that it is a sustainable and delicious superfood. BUG's argues that its recipe kits make it easy to cook tasty insect meals at home. It will initially sell its kits Direct-To-Consumer (DTC) and expand into retail and food services by 2022. The company averaged a 30%+ Month-on-Month (MoM) growth rate of meals that it sold during its beta testing. It aims to become a contender in the estimated £1.1 billion insect protein market across the UK. The company's recipes have been showcased by celebrity Chef Prue Leith. BUG has been featured in media entities like The Guardian, The Grocer and Business Insider. It will use the investment to scale the business and begin getting its tasty grub on dinner tables across the country
days to go:
Expired
investment:
£372,855
Cannabrew is one of the UK's first Cannabidiol (CBD) infused craft beers. It aspires to become a contender in the CBD market that is expected to reach £1 billion by 2025 in the UK. The company has sold thousands of cans across the UK despite COVID-19 and aims to become carbon-neutral soon. It assets that it plants two trees for every case of beer sold and has planted over 14,000 trees through a sustainability initiative in Madagascar by partnering with 'Ecologi', removing an estimated 350 tonnes of CO2 in just six months since the company's launch. Cannabrew was nominated for three awards at the World CBD Awards. Its product, Soul Lager, has become the highest-rated lager on Untappd in the UK achieving a score of >3.96. The company will use 25% of the investment in marketing, 50% towards team expansion, and 25% to scale production and boost New Product Development (NPD).
days to go:
Expired
investment:
£216,695
